Recent Finacing
Recent Raise
LIfT BioSciences develops N‑LIfT allogeneic immunomodulatory alpha neutrophils (IMANs) from donor iPSC/HSC using proprietary enhancement media and genetic engineering to enable scalable, antigen‑independent tumor‑killing and immune recruitment.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
